Abstract-Endothelial dysfunction in the setting of cardiovascular risk factors, such as hypercholesterolemia, hypertension, diabetes mellitus, chronic smoking, as well as in the setting of heart failure, has been shown to be at least partly dependent on the production of reactive oxygen species (ROS), such as the superoxide radical, and the subsequent decrease in vascular bioavailability of nitric oxide (NO). Superoxide-producing enzymes involved in increased oxidative stress within vascular tissue include the NAD(P)H oxidase, the xanthine oxidase, and mitochondrial superoxideproducing enzymes. Superoxide produced by the NADPH oxidase may react with NO released by endothelial nitric oxide synthase (eNOS), thereby generating peroxynitrite. Peroxynitrite in turn has been shown to uncouple eNOS, thereby switching an antiatherosclerotic NO-producing enzyme to an enzyme that may initiate or even accelerate the atherosclerotic process by producing superoxide. Increased oxidative stress in the vasculature, however, is not restricted to the endothelium and has also been demonstrated to occur within the smooth muscle cell layer in the setting of hypercholesterolemia, diabetes mellitus, hypertension, congestive heart failure, and nitrate tolerance. Increased superoxide production by the endothelial and/or smooth muscle cells has important consequences with respect to signaling by the soluble guanylyl cyclase (sGC) and the cGMP-dependent protein kinase I (cGK-I), the activity and expression of which has been shown to be regulated in a redox-sensitive fashion. The present review summarizes current concepts concerning eNOS uncoupling and also focuses on the consequences for downstream signaling with respect to activity and expression of the sGC and cGK-I in various diseases. T raditionally, the role of the endothelium was thought primarily to be that of a selective barrier to the diffusion of macromolecules from the vessel lumen to the interstitial space. During the past 20 years, numerous additional roles for the endothelium have been defined such as regulation of vascular tone, modulation of inflammation, promotion, and inhibition of vascular growth and modulation of platelet aggregation and coagulation. Endothelial dysfunction is a characteristic feature of patients with coronary atherosclerosis and more recent studies indicate that it may predict long-term atherosclerotic disease progression as well as cardiovascular event rate. 1 Although the mechanisms underlying endothelial dysfunction may be multifactorial, there is a growing body of evidence that increased production of reactive oxygen species (ROS) may contribute considerably to this phenomenon. ROS production has been demonstrated to occur in the endothelial cell layer, but also within the media and adventitia, all of which may impair nitric oxide (NO) signaling within vascular tissue to endotheliumdependent, but also endothelium-independent, vasodilators.
T raditionally, the role of the endothelium was thought primarily to be that of a selective barrier to the diffusion of macromolecules from the vessel lumen to the interstitial space. During the past 20 years, numerous additional roles for the endothelium have been defined such as regulation of vascular tone, modulation of inflammation, promotion, and inhibition of vascular growth and modulation of platelet aggregation and coagulation. Endothelial dysfunction is a characteristic feature of patients with coronary atherosclerosis and more recent studies indicate that it may predict long-term atherosclerotic disease progression as well as cardiovascular event rate. 1 Although the mechanisms underlying endothelial dysfunction may be multifactorial, there is a growing body of evidence that increased production of reactive oxygen species (ROS) may contribute considerably to this phenomenon. ROS production has been demonstrated to occur in the endothelial cell layer, but also within the media and adventitia, all of which may impair nitric oxide (NO) signaling within vascular tissue to endotheliumdependent, but also endothelium-independent, vasodilators.
More recent experimental, but also clinical, studies point to a crucial role of endothelial nitric oxide synthase (eNOS) as a superoxide-producing enzyme in the setting of atherosclerosis, hypertension, congestive heart failure, and also nitrate tolerance. Figure 1 summarizes our observations that in all these pathophysiological settings vascular oxidative stress, as visualized by dihydroethidine-dependent fluorescence, is present within the endothelium, but also the smooth muscle cell layer and the adventitia, all of which plays an important role for the development of endothelial and/or vascular dysfunction. This review briefly addresses mechanisms underlying eNOS uncoupling and focuses on the consequences with respect to the activity and/or expression of the NO target, the soluble guanylyl cyclase (sGC), and the cGMPdependent protein kinase I (cGK-I) present in vascular smooth muscle.
The L-arginine/NO/cGMP Pathway in Vascular Tissue
The endothelium, a single-layered continuous cell sheet lining the luminal vessel wall, separates the intravascular (blood) from the interstitial compartment and the vascular smooth muscle. Based on cell count (6ϫ10 13 ), mass (1.5 kg), and surface area (1000 m 2 ), the endothelium is an autonomous organ. Though for long time regarded as a passive barrier for blood cells and macrosolutes, this view completely changed with the advent of endothelial autacoids like prostacyclin 2 and NO, 3 as well as with the discovery of integrins and other surface signals. 4 It is now evident that the endothelium is at the cross-bridges of communication between blood and tissue cells and actively controls this process and the function of surrounding cells by a plethora of signaling routes. One of the prominent communication lines is established by the so-called L-arginine-NO-cyclic GMP pathway. 5 This signaling cascade starts with eNOS (NOSIII), which generates NO and L-citrulline from L-arginine and O 2 in response to receptor-dependent agonists (bradykinin, acetylcholine, ATP) and physicochemical stimuli (shear, stretch). 6 Reducing equivalents are provided by NADPH, and electrons are passed via a flavin chain to the catalytic center, the enzymes heme iron (Figure 2 , upper). The first step of the normal NOS reaction is a classical mono-oxygenation, which consumes 1 mol of NADPH and oxygen. Molecular oxygen bound to the iron is activated and split to accomplish a hydroxylation of the substrate, the guanidino-nitrogen of L-arginine, forming N G -hydroxy-L-arginine. The second step is an atypical mono-oxygenation, which consumes 1 mol O 2 and 0.5 mol NADPH. It is a 3-electron oxidation of N Ghydroxy-L-arginine to afford the final products NO and L-citrulline. To guarantee this reaction path, the enzyme has to be homodimeric and the cofactor tetrahydrobiopterin must be present (Figure 2 ). For details, the reader is referred to excellent reviews on this topic. 7, 8 NO diffuses to the adjacent smooth muscle where it interacts with different receptor molecules, of which the sGC is the best characterized and presumably most important one with regard to control of vessel tone and smooth muscle proliferation. The catalytically active holoenzyme exists as an obligate heterodimer consisting of one ␣ and one ␤ subunit and a noncovalently bound ferrous heme. 9 The most abundant isoform in mammalian tissues is the ␣ 1 (73 to 78 kDa)/␤ 1 (70 kDa) heterodimer. Significant protein expression of 2 other homologues subunits has only been detected in the human placenta (␣ 2 ) 10,11 and kidney (␤ 2 ). 12 At the genomic level, a dominant-negative splice variant of ␣ 2 classified as ␣ 2i has been detected. 13 The interspecies homology of the individual subunits is high, whereas the intersubunit homology is lower. 14 In contrast to ␣ 1 and ␤ 1 , the biological significance of ␣ 2 , ␣ 2I , and ␤ 2 is still obscure. The ␣ 2 subunit has recently been shown to be linked to cerebral maturation and sensory pathway refinement during postnatal development. 15 A unifying concept of the molecular requisites for sGC activation has been put forth. 16, 17 Activation by NO requires sGC heme iron to be in the ferrous (II) state. On NO binding, the iron is moved slightly out of the porphyrin plane, thereby releasing a distal histidine (His 105 of the ␤ 1 subunit) from iron coordination. 18 This triggers subsequent intramolecular rearrangements influencing the catalytic center, resulting in an up to several-hundred-fold increase in cGMP formation. Depending on the cell type, cyclic GMP then elicits different biological responses, either by inhibition (cAMPmetabolizing phosphodiesterases) or by activation (cGMPactivated protein kinases, cGK, and cGMP-gated cation channels) of effector proteins. 19 A comprehensive overview on cGK-I downstream signaling is provided. 19 The mammalian cGK family consists of cGK-I␣, a splice variant cGK-I␤, and cGK-II, which is encoded by a separate gene. 19 Both cGK-I isoforms, not cGK-II, are expressed in vascular cells. In rat aortic smooth muscle cells, activated cGK-I␣ increases the open probability of Ca 2ϩ -activated K ϩ (B K ) channels, thereby inducing a hyperpolarization of the smooth muscle cells and inhibition of agonist-induced Ca 2ϩ influx. In addition, activated cGK-I␤ phosphorylates the inositol triphosphate receptor-associated G-kinase substrate, thereby inhibiting agonist-induced Ca 2ϩ release and smooth muscle contraction. Another cGK-I substrate found in many cell types is the 46/50 kDa vasodilator-stimulated phosphoprotein. cGK-I phosphorylates vasodilator-stimulated phosphoprotein specifically at serine 239, and this reaction can be exploited as a biochemical monitor for the integrity and activity of the NO-cGMP pathway, 20 as discussed. Phosphorylation and activation of cGMP-hydrolyzing phosphodiesterase 5 by cGK-I is a major mechanism to cease cGMP signaling. 19, 21 Oxidative Stress and Endothelial Dysfunction
The endothelium-derived relaxing factor, previously identified as NO 3 or a closely related compound, 22 has potent anti-atherosclerotic properties. NO released from endothelial cells works in concert with prostacyclin to inhibit platelet aggregation, 23 it inhibits the attachment of neutrophils to endothelial cells and the expression of adhesion molecules. NO in high concentrations inhibits the proliferation of smooth muscle cells. 24 Therefore, under all conditions in which an absolute or relative NO deficit is encountered, the process of atherosclerosis is being initiated or accelerated. The half-life of NO and therefore its biological activity is decisively determined by oxygen-derived free radicals such as superoxide. 25 Superoxide rapidly reacts with NO to form the highly reactive intermediate peroxynitrite. 26 The rapid bimolecular reaction between NO and superoxide yielding peroxynitrite (rate constant: 5 to 10 ϫ 10 9 M Ϫ1 s Ϫ1 ) is Ϸ3-to 4-times faster than the dismutation of superoxide by the superoxide dismutase. Therefore, peroxynitrite formation represents a major potential pathway of NO reactivity pending on the rates of tissue superoxide production. Peroxynitrite in high concentrations is cytotoxic and may cause oxidative damage to proteins, lipids, and DNA. 26 Recent studies also indicate that peroxynitrite may have deleterious effects on activity and function of the prostacyclin synthase 27 and the eNOS. 28 Other ROS such as the dismutation product of superoxide, hydrogen peroxide, and the hypochlorous acid released by activated neutrophils, are not free radicals, but have a powerful oxidizing capacity, which will further contribute to oxidative stress within vascular tissue.
Endothelial Dysfunction and Cardiovascular Risk Factors
It is well known that in the presence of cardiovascular risk factors endothelial dysfunction is frequently encountered. This has been shown for chronic smokers, patients with increased low-density lipoprotein levels, for patients with diabetes types I and II, for hypertensive patients, and for patients with metabolic syndrome. There are several potential abnormalities, which could account for reductions in endothelium-dependent vascular relaxation including changes in the activity and/or expression of the eNOS, decreased sensitivity of vascular smooth muscle cells to NO, or increased degradation of NO via its interaction with ROS such as superoxide. The NO degradation concept is the most attractive one because in the presence of cardiovascular risk factors, endothelial dysfunction is established and even more importantly it is markedly improved by the acute administration of the antioxidant vitamin C. 29 -32 Superoxide and/or peroxynitrite could also act further downstream by oxidative inactivation of sGC as well as activation of cGK-I.
eNOS Uncoupling Contributes to Endothelial Dysfunction
In most situations in which endothelial dysfunction caused by increased oxidative stress is encountered, the expression of the eNOS has been shown to be paradoxically increased rather than decreased. [33] [34] [35] [36] The mechanisms underlying increased expression of eNOS are likely to be secondary to increased endothelial levels of hydrogen peroxide, which has been shown to increase the expression at the transcriptional and translational level. 37 The demonstration of endothelial dysfunction in the presence of increased expression of eNOS indicates that the capacity of the enzyme to produce NO may be limited. Very intriguing are observations that the eNOS itself can be a superoxide source, thereby causing endothelial dysfunction. It has become clear from studies with the purified enzyme that eNOS may become "uncoupled," eg, in the absence of the NOS substrate L-arginine or the cofactor tetrahydrobiopterin (BH 4 ). In such uncoupled state, electrons normally flowing from the reductase domain of one subunit to the oxygenase domain of the other subunit are diverted to molecular oxygen rather than to L-arginine, 38, 39 resulting in production of superoxide rather than NO ( Figure 2 ). That eNOS-derived superoxide/ROS formation bears consequences opposite to "normal" NOS function was first shown in U937 cells transfected with wild-type eNOS, which induced increased transcription of tumor necrosis factor-␣ in an NOS inhibitor (L-NMA)-insensitive and superoxidedismutase-sensitive fashion. 40 We discuss several possibilities how eNOS uncoupling may occur.
eNOS Uncoupling Caused by Increased Peroxynitrite-Mediated BH 4 Oxidation
For proper function of NOS, BH 4 seems to be essential in several ways. BH 4 stabilizes the NOS dimer, facilitates its formation, and protects NOS against proteolysis. 41, 42 It also increases the affinity of NOS for L-arginine and affects the spin state of the heme iron, the heme redox potential, and the oxygen binding. Most importantly, however, BH 4 plays a decisive role for oxygen activation and the time-critical delivery of one electron and proton to the Fe(II)-O 2 intermediate, which converts to an iron-oxo species and releases H 2 O in the catalytic cycle of NOS. 43 BH 4 provides the second electron in the first mono-oxygenation reaction that hydroxylates L-arginine to N-hydroxy-arginine. Rapid kinetics analysis by freeze-quench EPR revealed the transient formation of a BH 4 ϩ⅐ cation radical during this reaction, which rapidly splits off a proton to form a BH 3 ⅐ radical. The BH 3 ⅐ radical is reduced by one electron and proton delivered by the reductase domain to BH 4 , which participates in a second oxygen activation step leading to the final products NO and L-citrulline. In the absence of BH 4 , the Fe(II)-O 2 intermediate decays under formation of superoxide and Fe(III). Dihydrobiopterin (BH 2 ) and other derivatives such as sepiapterin can bind to NOS but cannot support NO formation. 43 Therefore, limited availability of BH 4 for NOS will inevitably result in increased superoxide formation at the expense of NO formation, ie, it will uncouple NOS.
What are the mechanisms leading to BH 4 depletion? In vitro studies proposed that native low-density lipoprotein 44 and even more pronounced oxidized low-density lipoprotein 45 are able to stimulate endothelial superoxide production and that this phenomenon is inhibited by the NOS inhibitor L-NAME, pointing to a specific role of eNOS in superoxide production. Hypercholesterolemia also has been shown to increase vascular formation of superoxide via activation of the NAD(P)H oxidase 46 and/or xanthine oxidase. 47 Superoxide derived from both enzyme sources may lead to increased formation of peroxynitrite. 33, 48 Peroxynitrite in turn rapidly oxidizes the active NOS cofactor BH 4 to cofactor inactive molecules such as BH 2 . 33, 49 These concepts, however, also imply that the uncoupling of eNOS would invariably require a priming event such as superoxide produced by the NAD(P)H oxidase and/or the xanthine oxidase (so-called kindling radicals) leading via increased formation of peroxynitrite eNOS to produce superoxide (bonfire radical).
eNOS Uncoupling Caused by Peroxynitrite-Mediated Oxidation of the Zinc-Thiolate Complex
Another interesting concept concerning eNOS uncoupling was provided by Zou et al. These authors showed that the exposure of the isolated enzyme to peroxynitrite leads to a disruption of the zinc-thiolate cluster resulting in an uncoupling of the enzyme. 28 The authors also demonstrated that a similar phenomenon occurred when endothelial cells were exposed to high concentrations of glucose. Additional experiments revealed that BH 4 was oxidized at concentrations being 10-to 100-fold higher than those needed to disrupt the zinc-thiolate complex. Based on these findings, the authors suggested that the principal mechanism of uncoupling is the oxidation of the zinc-thiolate center and the subsequent release of Zn 2ϩ ions rather than BH 4 oxidation. 28 
eNOS Uncoupling Caused by L-Arginine Deficiency or Increased Production of Asymmetrical Methyl Arginine
Several recently published studies demonstrate that increased concentrations of asymmetrical methyl arginines (ADMA) in cultured endothelial cells or in patients with endothelial dysfunction are associated with increased ROS production in supernatants, rodents, or human plasma. 50 -52 The question is whether increased ROS production is the reason for increased ADMA levels or whether increased production of ADMA actually contributes to the oxidative stress burden of the vasculature via uncoupling of eNOS. Interestingly, the activity of methylating enzymes such as the S-adenosylmethionine-dependent PRMTs (type I) 51 responsible for the ADMA synthesis or the activity of ADMA hydrolyzing enzymes such as DDAH 50 is redox-sensitive. Thus, oxidative stress in the vasculature should always stimulate ADMA production and/or inhibit ADMA degradation in concentrations that significantly inhibit eNOS activity or even uncouple the enzyme, which would further increase superoxide production in a positive feedback fashion. 53
Which Enzyme Produces the Kindling Radical for Increased Peroxynitrite Formation Ultimately Leading to eNOS Uncoupling? Role for NAD(P)H Oxidase
The NAD(P)H oxidase is a superoxide-producing enzyme that has been first characterized in neutrophils. 54 We know that a similar enzyme exists also in endothelial and smooth muscle cells, as well as in the adventitia. The activity of the enzyme in endothelial as well as smooth muscle cells is increased on stimulation with angiotensin II. 55 The stimulatory effects of angiotensin II on the activity of this enzyme would suggest that in the presence of an activated renin angiotensin system (local or circulating), vascular dysfunction caused by increased vascular superoxide production is likely to be expected. Experimental hypercholesterolemia has been shown to be associated with an activation of the NAD(P)H oxidase 46 and there is a close association with endothelial dysfunction and clinical risk factors and the activity of this enzyme in human saphenous veins in patients with coronary artery disease. 56 In atherosclerotic arteries there is evidence for increased expression of the NAD(P)H oxidase subunit gp91phox and nox4, all of which may contribute to increased oxidative stress within vascular tissue. 57 Interestingly, there is growing body of evidence that the local renin angiotensin system is activated in the setting of hypercholesterolemia. In patients, ACE activity and therefore local angiotensin II concentrations are increased in atherosclerotic plaques, 58, 59 and inflammatory cells are capable of producing large amounts of angiotensin II. Increased angiotensin II concentrations along with increased levels of superoxide have been shown in the shoulder region of atherosclerotic plaques. 60 In vessels from hypercholesterolemic animals 46 as well as in platelets from hypercholesterolemic patients, 61 there is an increase in the expression of the angiotensin II receptor subtype AT 1 . Thus, both experimental and clinical studies have provided evidence for stimulation of the renin angiotensin system in atherosclerosis and simultaneously for an activation of the NAD(P)H oxidase in the arterial wall. Similar evidence for an activation of this enzyme in the vasculature has been provided from experimental animal models of different forms of hypertension such as angiotensin II infusion 62, 63 and in SHR, 64 as well as in different forms of diabetes mellitus. 35 The proof of concept that superoxide produced by the NADPH oxidase may indeed trigger eNOS uncoupling was provided by David Harrison's group in the experimental animal model of DOCA-salt hypertension. With these studies, the authors showed that superoxide induced by DOCAsalt treatment caused increased vascular superoxide production, which was significantly reduced by an inhibitor of eNOS such as L-NAME. Treatment of p47phox knockout animals with DOCA-salt caused markedly reduced levels of oxidative stress and abolished superoxide effects of NOS inhibition compatible with a prevention of eNOS uncoupling. 65 
Role for Xanthine Oxidase
Xanthine oxido-reductase catalyzes the sequential hydroxylation of hypoxanthine to yield xanthine and uric acid. The enzyme can exist in 2 forms that differ primarily in their oxidizing substrate specificity. The dehydrogenase form preferentially uses NAD ϩ as an electron acceptor but is also able to donate electrons to molecular oxygen. By proteolytic breakdown as well as thiol oxidation, xanthine dehydrogenase from mammalian sources can be converted to the oxidase form that readily donates electrons to molecular oxygen, thereby producing superoxide and hydrogen peroxide but does not reduce NAD ϩ . Oxypurinol, an inhibitor of xanthine oxidoreductase, has been shown to reduce superoxide production and to improve endothelium-dependent vascular relaxations to acetylcholine in vessels from hyperlipidemic animals. 47 This suggests an increase in the expression or activity of xanthine oxidase in early hypercholesterolemia. The mechanisms underlying such a phenomenon remain unclear; however, it has been demonstrated that certain cytokines can stimulate the expression of xanthine oxidase by the endothelium. An alternative mechanism may be that increased cholesterol levels trigger the release of xanthine oxidase (eg, from the liver) into the circulation where it binds to endothelial glycosaminoglycans. 66 Human studies concerning the efficacy of xanthine oxidase inhibition on endothelial dysfunction are somewhat discrepant. Although Panza et al showed that endothelial dysfunction in hypercholesterolemic patients and hypertensive diabetic subjects is improved by acute inhibition of xanthine oxidase with oxypurinol and allopurinol, 67, 68 other groups failed to show similar efficacy 69 for allopurinol. Its role in mediating increased oxidative stress in the setting of hypertension is not quite clear. Oxypurinol has blood pressure-lowering effects comparable to heparin-binding SOD in SHR 70 but fails to demonstrate a positive effect on endothelial dysfunction in hypertensive patients. 67 
How Can We Assess eNOS Uncoupling?
It is important to note that eNOS-mediated superoxide production-by the isolated enzyme or in vascular tissue-is inhibited by N G -nitro-L-arginine (L-NNA) and its methylester N G -nitro-L-arginine methylester (L-NAME), because both substances antagonize the transfer of electrons to either L-arginine or oxygen. In contrast, L-NMMA has been previously shown to stimulate rather than to inhibit superoxide production by the isolated enzyme because of partial uncoupling of NADPH oxidation (electron transfer to oxygen). This has been shown for inducible NOS 71 and for neuronal NOS. 72 Similar phenomena may have to be expected when isolated enzymes are exposed to the structurally similar ADMA, which will prevent the oxidation of L-arginine and therefore reduce NO production or, as mentioned, will stimulate superoxide production by competing for the same binding site of the enzyme.
The L-NNA-sensitive and L-NAME-sensitive inhibition of superoxide formation is a convenient method to detect uncoupling of NOS in vascular tissues. Depending on the detection system used, addition of these NOS inhibitors to vascular cells and tissues will decrease the superoxidederived signal, such as lucigenin-dependent (5 mol/L) luminescence or the dihydroethidine fluorescence. 73, 74 The Harrison group showed that depletion of endogenous BH 4 in mouse aorta by addition of exogenous peroxynitrite increased superoxide formation, and that addition of L-NAME, removal of the endothelium, or genetic knockout of eNOS prevented this radical response. [33] [34] [35] [36] 
Modulation of the Activity and Expression of the sGC and cGK-I In Vitro by ROS and Effects of Oxidative Stress on the Activity and Expression of the sGC and cGK-I In Vivo
See http://atvb.ahajournals.org for details.
Summary and Conclusions
Taken together, there is mounting evidence that endothelial dysfunction of the coronary or peripheral circulation has important prognostic implications for future cardiovascular events. Although the mechanisms underlying endothelial dysfunction are likely multifactorial (Figure 3) , it is important to note that increased production of oxygen-derived free radicals by an uncoupled eNOS markedly contributes to this phenomenon. Increased superoxide production is not restricted to the endothelium but also involves the smooth muscle cell layer, where reactive oxygen species affect NO/cGMP signaling by altering the expression of sGC and by inhibiting the activity of the sGC and cGK-I. , increasing cGMP, thus stimulating cGMP-dependent protein kinase I (cGK-I) and eliciting vasorelaxation. cGK-I also phosphorylates vasodilator-stimulated phosphoprotein, which can be taken as a biochemical marker of cGK-I activity. This pathway can, however, be inhibited at several sites. Angiotensin II, hypertension, hypercholesterolemia, chronic smoking, nitrate tolerance, and diabetes mellitus stimulate superoxide (O 2 . ) production within endothelial and smooth muscle cells and in the adventitia, which may inactivate NO and inhibit sGC directly, thereby diminishing cGK-I activity. Peroxynitrite (ONOO Ϫ ) may also inhibit sGC directly and it uncouples NOSIII by oxidizing Zn-thiolate complexes within NOSIII, and/or by oxidizing the NOS cofactor tetrahydrobiopterin (BH 4 ) to dihydrobiopterin (BH 2 ). This concept, however, also means that uncoupling of NOSIII would always require a priming event such as superoxide produced by the NAD(P)H oxidase and/or xanthine oxidase. Angiotensin II and nitroglycerin (NTG) also increase catabolism of cGMP by phosphodiesterase 1A1 (PDE1A1), which is usually accomplished by phosphodiesterase 5. sGC expression was paradoxically found to be increased, whereas in other models it was reduced (Table 1) 14 One of these factors is the ubiquitious 34 kDa protein HuR, also known as HuA. 15 HuR binds to AREs present in the 3'-UTR of target mRNAs, thereby protecting these mRNA from accelerated decay. 16 The decisive role of HuR for regulation of sGC expression was proven by siRNA-induced knock-down of HuR in rat aortic smooth muscle cells, which led to a concomitant decrease in sGC expression 17 .
Furthermore, prolonged (6 h methylester L-NAME, strongly decreased P-VASP levels. 28, 29 Likewise, NO donors such as SNP and NTG markedly increased P-VASP in vessels in the absence and presence of an intact endothelium. 28, 29 Mechanical removal of the endothelium in rat and rabbit aorta almost completely abolished "basal" VASP phosphorylation, whereas total VASP levels (phosphorylated and non-phosphorylated) were reduced by about 40-50 %. 28 markedly reduced P-VASP levels. 28 Concomitantly, basal endothelial NO formation was decreased and formation of superoxide was increased 28 . However, in a more recent study sGC expression was found to be reduced in the same animal model, especially in the neo-intima, which accounted for 60 % of the aortic tissue, and NO-sensitive sGC activity was significantly lower compared to control vessels 36 . These discrepant findings might result from the different feeding regimes applied: while in the first study the rabbits were fed for a short period 53 .
Effects of oxidative
Thus, it appears that the decrease in sGC expression elicited by high blood pressure is not exclusively 77 These authors
showed that in the absence of thiols NTG directly oxidized sGC heme-iron, thereby preventing NOdependent activation of sGC in vitro. 77 The availability of specific activators of heme-oxidized sGC 78 should help to clarify whether or not nitrate tolerance is mediated in part on oxidation of the sGC heme-iron in intact cells.
Whereas sGC expression in the setting of in vivo tolerance was increased, and sGC activity decreased, cGK-I expression was not changed in aortas from rabbits and rats 19 and mammary arteries 79 from NTG-treated animals and patients.
These data contrast to those of Soff et al. 80 Although tolerance resulting from in vivo NTG treatment did lead to changes in cGK-I expression, it significantly decreased cGK-I activity (P-VASP levels) in aortas from rats and rabbits, 19 and in the mammary artery from patients undergoing coronary artery bypass surgery. 79 Incubation of tolerant tissue with SNP elicited normal increases in P -VASP levels, indicating that the cGMP-signaling pathway downstream of sGC was not impaired. 19 Further results supported the concept that ROS markedly contributed to t he nitrate tolerance and cross tolerance, 19 which was detected as inhibition of cGK-I activity. Treatment with vitamin C reduced superoxide l evels, restored P -VASP levels, and partially corrected tolerance. 19 Constitutive expression of sGC subunits a 1 and ß 1 is the net result of "house-keeping" transcription and mRNA stability regulated by the mRNA protecting protein HuR. Increased NO levels via route 1 to 5 (red) decrease
HuR expression via a cGMP/cGK-I/AP-1 activation dependent mechanism, promoting degradation of sGC subunit mRNAs and thereby reducing sGC protein synthesis. Conversely, increased superoxide levels via steps 2 to 4 (blue) activate redox-sensitive transcription factors (RSTF), increase transcription of sGC subunits, thereby leading to increased sGC protein expression. In addition, increased superoxide also increases sGC protein synthesis by inhibiting cGMP formation and stabilizing sGC mRNA via route 1 to 5 (red). 
